08:35 26 December
in
About Center
CDHS Inc is a Substance Abuse Treatment Services rehab center located in Arlington, TX. This drug & alcohol rehab center based in Texas provides Outpatient Methadone/Buprenorphine or Vivitrol,Outpatient,Regular Outpatient Treatment as treatment service option. For CDHS Inc reviews, ratings & other information, please read below.
Exclusive services
- Methadone and Buprenorphine Clients Only
- All Clients in Opioid Treatment Program
Language Services
- Spanish
Type of care
- Substance Abuse Treatment Services
Service Setting (e.g., Outpatient, Residential, Inpatient etc.)
- Outpatient Methadone/Buprenorphine or Vivitrol
- Outpatient
- Regular Outpatient Treatment
Opioid Medications
- Buprenorphine used in Treatment
- Methadone used in Treatment
Opioid Treatment
- Buprenorphine maintenance
- Methadone maintenance
- SAMHSA-certified Opioid Treatment Program
Pharmacotherapies
- Buprenorphine with naloxone (Suboxone®)
- Methadone
Facility Operation (e.g., Private, Public)
- Private Organization
Certification
- The Joint Commission
- State substance abuse agency
- State department of health
Payment /Insurance/Funding Accepted
- Cash or Self-payment
Assessment
- Comprehensive substance abuse assessment
- Outreach to persons in the community
Screening
- Drug or alcohol urine screening
- Screening for Hepatitis B
- Screening for substance abuse
- STD testing
- TB screening
Transitional Services
- Discharge Planning
Ancilliary Services
- Assistance with obtaining social servicest
- Case management
- Housing services
- Consumer-run (peer-support) services
- Social skills development
Facility Smoking Policy
- Smoking Permitted in Designated Area
Age Groups Accepted
- Adults
- Young Adults
Gender Accepted
- Female
- Male
Counselling Services
- Family counseling offered
- Group counseling offered
- HIV or AIDS education
- counseling
- or support
- Individual counseling offered
- Marital/couples counseling offered
- Substance abuse education
Directions to Center
Related Rehab Centers
Sorry, the comment form is closed at this time.